← Eichor
Study identifier: NCT04274179 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ketogenic Diet for New-Onset Absence Epilepsy

Condition: Absence Epilepsy · Ketogenic Dieting · Epilepsy, Absence  ·  Sponsor: Johns Hopkins University

PhasePhase 3
Planned participants40
Who can joinAll sexes, 3 Years to 12 Years
Healthy volunteersNo

About this study

The ketogenic diet is a medical therapy for epilepsy that is used nearly predominantly for refractory epilepsy (after 2-3 drugs have been tried and failed). However, there is both published evidence for first-line use (infantile spasms, Glut1 deficiency syndrome) and also anecdotal experience (families choosing to change the child's (or the family' own) diet rather than use anticonvulsant medications). Childhood absence epilepsy (refractory) has been published as being responsive to ketogenic diet therapy by the investigators' group previously. This is a small, prospective, 3 month trial to assess if using a modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy. The investigators will compare to a group of children in which the parents have declined and chose to start anticonvulsant medications.

This description comes directly from the study's public registry record.

Talk to the study team

Eric H Kossoff, MD  ·  4109559100  ·  ekossoff@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins HospitalBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04274179